Literature DB >> 33359929

National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations.

Rajkumar Doshi1, Mihir Dave2, Monil Majmundar3, Ashish Kumar4, Devina Adalja5, Mariam Shariff4, Rupak Desai6, Boback Ziaeian7, Saraschandra Vallabhajosyula8.   

Abstract

BACKGROUND: Atrial Fibrillation (AF) has been associated with various behavioral risk factors such as tobacco, alcohol, and/or substances abuse.
OBJECTIVE: The main objective is to describe the national trends and burden of tobacco and substance abuse in AF hospitalizations. Also, this study identifies potential population who are more vulnerable to these substance abuse among AF hospitalizations.
METHODS: The National Inpatient Sample database from 2007 to 2015 was utilized and the hospitalizations with AF were identified using the international classification of disease, Ninth Revision, Clinical Modification code. They were stratified into without abuse, tobacco use disorder (TUD), substance use disorder (SUD), alcohol use disorder (AUD) and drug use disorder (DUD).
RESULTS: Of 3,631,507 AF hospitalizations, 852,110 (23.46%) had TUD, 1,851,170 (5.1%) had SUD, 155,681 (4.29%) had AUD and 42,667 (1.17%) had DUD. The prevalence of TUD, SUD, AUD, and DUD was substantially increased across all age groups, races, and gender during the study period. Female sex was associated with lower odds TUD, SUD, AUD, and DUD. Among AF hospitalizations, the black race was associated with higher odds of SUD, and DUD. The younger age group (18-35 years), male, Medicare/Medicaid as primary insurance, and lower socioeconomic status were associated with increased risk of both TUD and SUDs.
CONCLUSION: TUD and SUD among AF hospitalizations in the United States mainly affects males, younger individuals, white more than black, and those of lower socioeconomic status which demands for the development of preventive strategies to address multilevel influences.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Drug abuse; Substance abuse; Tobacco abuse; Trends

Mesh:

Year:  2020        PMID: 33359929      PMCID: PMC8310779          DOI: 10.1016/j.hrtlng.2020.12.009

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  44 in total

1.  Racial/ethnic variations in substance-related disorders among adolescents in the United States.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Jeng-Jong Pan; Dan G Blazer
Journal:  Arch Gen Psychiatry       Date:  2011-11

2.  Association Between Opioid Use and Atrial Fibrillation: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Waqas T Qureshi; Wesley T O'Neal; Yulia Khodneva; Suzanne Judd; Monika M Safford; Paul Muntner; Elsayed Z Soliman
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

3.  Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.

Authors:  Hongli Shan; Yong Zhang; Yanjie Lu; Ying Zhang; Zhenwei Pan; Benzhi Cai; Ning Wang; Xuelian Li; Tieming Feng; Yuan Hong; Baofeng Yang
Journal:  Cardiovasc Res       Date:  2009-04-27       Impact factor: 10.787

4.  Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study.

Authors:  Jan Heeringa; Jan A Kors; Albert Hofman; Frank J A van Rooij; Jacqueline C M Witteman
Journal:  Am Heart J       Date:  2008-10-14       Impact factor: 4.749

5.  Comparison of Management and Outcomes of Acute Heart Failure Hospitalization in Medicaid Beneficiaries Versus Privately Insured Individuals.

Authors:  Samarthkumar Thakkar; Monil Majmundar; Ashish Kumar; Tikal Kansara; Devina Adalja; Irtqa Ilyas; Rupak Desai; Rajkumar Doshi
Journal:  Am J Cardiol       Date:  2020-04-01       Impact factor: 2.778

6.  Neighborhood socioeconomic status and substance use by U.S. adults.

Authors:  Katherine J Karriker-Jaffe
Journal:  Drug Alcohol Depend       Date:  2013-05-31       Impact factor: 4.492

7.  Alcohol Abstinence in Drinkers with Atrial Fibrillation.

Authors:  Aleksandr Voskoboinik; Jonathan M Kalman; Anurika De Silva; Thomas Nicholls; Benedict Costello; Shane Nanayakkara; Sandeep Prabhu; Dion Stub; Sonia Azzopardi; Donna Vizi; Geoffrey Wong; Chrishan Nalliah; Hariharan Sugumar; Michael Wong; Emily Kotschet; David Kaye; Andrew J Taylor; Peter M Kistler
Journal:  N Engl J Med       Date:  2020-01-02       Impact factor: 91.245

8.  Prevalence of cardiovascular risk factors and financial burden in younger adults hospitalized with atrial fibrillation.

Authors:  Jay Shah; Ashish Kumar; Monil Majmundar; Devina Adalja; Abhi Doshi; Rupak Desai; Palakkumar Patel; Rajkumar Doshi
Journal:  Heart Lung       Date:  2020-02-19       Impact factor: 2.210

9.  National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients.

Authors:  Sarah C Snow; Gregg C Fonarow; Joseph A Ladapo; Donna L Washington; Katherine J Hoggatt; Boback Ziaeian
Journal:  Am J Med       Date:  2018-12-16       Impact factor: 4.965

10.  Tobacco Product Use and Associated Factors Among Middle and High School Students - 
United States, 2019.

Authors:  Teresa W Wang; Andrea S Gentzke; MeLisa R Creamer; Karen A Cullen; Enver Holder-Hayes; Michael D Sawdey; Gabriella M Anic; David B Portnoy; Sean Hu; David M Homa; Ahmed Jamal; Linda J Neff
Journal:  MMWR Surveill Summ       Date:  2019-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.